DPIIT recognised startup Government of India
Startup India
Bioras Pharma Private Limited
Bioras Pharma Private Limited - pharma in Gandipet, Telangana, India. FY 2026 financials & compliance.
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
About Bioras Pharma Private Limited
Data last updated:
Bioras Pharma Private Limited is a private limited company based in Gandipet, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2021PTC153970. Its GSTIN is 36AAKCB0607K1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Rachana Tripathi and Sreeman Kumar Mamidyala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Syno 30 Narsingi, Gandipet, Telangana, India – 500075.
The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.02 Cr; the latest was in July 2023.
Bioras Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0065616).
Company details
CIN U24239TG2021PTC153970
Registration Number 153970
Incorporation Date 10 August 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0065616
Key People
Rachana Tripathi Director Sreeman Kumar Mamidyala Director Shesheer Kumar Munpally Director Recognitions & Rankings of Bioras Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0065616
Contact details
Bioras Pharma Private Limited's registered office is in Gandipet, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSyno 30 Narsingi, Gandipet, Telangana, India – 500075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bioras Pharma Private Limited, buy the company report.
Comprehensive company report
Bioras Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Bioras Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Bioras Pharma Private Limited, buy the company report.
Board of directors of Bioras Pharma Private Limited
Bioras Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rachana Tripathi | Director | 10 Aug 2021 | 5 Years 2 Months | Current |
| Sreeman Kumar Mamidyala Also directs: Atharwa Integrated Life Sciences (India) Private Limited | Director | 17 Jan 2022 | 4 Years 9 Months | Current |
| Shesheer Kumar Munpally Also directs: HLSS Manufacturing Private Limited, Sirf Bio Private Limited, Huwel Lifesciences Private Limited and 1 more | Director | 10 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Bioras Pharma Private Limited is audited by MURTHY & PRASAD & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MURTHY & PRASAD & CO | FY 2022 | 005930S |
Shareholding
The shareholding of Bioras Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bioras Pharma Private Limited, buy the company report.
Deals & funding
Bioras Pharma Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.02 Cr; the latest was in July 2023.
Total deals
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹1.02 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2023 | Funding round | ₹1 Cr | Investors: 4 individuals |
| Feb 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2022 | Funding round | ₹2 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Bioras Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioras Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bioras Pharma Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Bioras Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCB0607K1ZQ | Telangana | Active | 02 Dec 2021 |
To see the full GST registrations and return filing status of Bioras Pharma Private Limited, buy the company report.
Recent activity
Bioras Pharma Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Sreeman Kumar Mamidyala ceased to be Additional Director on 31 Mar 2023.
AGM
Bioras Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bioras Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Sreeman Kumar Mamidyala ceased to be Additional Director.
Ceased
Divleen Sidhu ceased to be Additional Director.
Appointed
Sreeman Kumar Mamidyala was appointed as Director.
Appointed
Rachana Tripathi was appointed as Director.
Appointed
Shesheer Kumar Munpally was appointed as Director.
Incorporation
10 Aug 2021
Bioras Pharma Private Limited was registered on 10 Aug 2021 with Roc Hyderabad & aged 5 years 2 months as per MCA records.
Frequently asked questions
Bioras Pharma is an active private limited company based in Gandipet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 August 2021 (5+ years old) and is registered under CIN U24239TG2021PTC153970.
Bioras Pharma has 3 current directors:
- Rachana Tripathi - Director
- Sreeman Kumar Mamidyala - Director
- Shesheer Kumar Munpally - Director
The latest financial statements of Bioras Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Bioras Pharma is 36AAKCB0607K1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Bioras Pharma is U24239TG2021PTC153970. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioras Pharma was incorporated on 10 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bioras Pharma has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.02 Cr; the latest was in July 2023.
Sreeman Kumar Mamidyala ceased to be Additional Director on 31 Mar 2023. Divleen Sidhu ceased to be Additional Director on 21 Feb 2023. Sreeman Kumar Mamidyala was appointed as Director on 17 Jan 2022. Bioras Pharma has 5 board changes on record in total.
Yes, Bioras Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Bioras Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0065616).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages